Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 7/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 6/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.38 |
| ▸ | RXRA | P19793 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.34 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7754457 | 1.00 | NR1H2 (0.39) | NR1H2NR1H3HIF1ARXRAKDM4E | |
| SCHEMBL7749531 | 0.93 | NR1H2 (0.38) | NR1H2NR1H3RXRAKDM4ESMN1; SMN2 | |
| SCHEMBL7749529 | 0.93 | NR1H2 (0.38) | NR1H2NR1H3RXRAKDM4ESMN1; SMN2 | |
| SCHEMBL7749562 | 0.92 | NR1H2 (0.38) | NR1H2NR1H3HIF1ARXRASMN1; SMN2 | |
| SCHEMBL7749565 | 0.92 | NR1H2 (0.38) | NR1H2NR1H3HIF1ARXRASMN1; SMN2 | |
| SCHEMBL7749510 | 0.91 | KDM4E (0.37) | NR1H2NR1H3HIF1ARXRAKDM4E | |
| SCHEMBL7749507 | 0.91 | KDM4E (0.37) | NR1H2NR1H3HIF1ARXRAKDM4E | |
| SCHEMBL7755669 | 0.89 | NR1H2 (0.36) | NR1H2NR1H3RXRAPTGER4 | |
| SCHEMBL7755672 | 0.89 | NR1H2 (0.36) | NR1H2NR1H3RXRAPTGER4 | |
| SCHEMBL7754241 | 0.87 | FOLH1 (0.40) | HIF1AKDM4ESMN1; SMN2FFAR1PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | CRAMP MICHAEL COLIN (GB) | 2001-10-11 | — | — | US | disclosed |
| WO-2001047863-A2 | NEW HERBICIDAL COMPOSITIONS | AVENTIS CROPSCIENCE SA (FR) | 2001-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | DDT, CYP1B1, CYP4X1 | NR1H2 1849/4885NR1H3 2372/4885HIF1A 2422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.